Provided by Tiger Fintech (Singapore) Pte. Ltd.

Instil Bio, Inc.

16.49
+0.49003.06%
Post-market: 16.40-0.0900-0.55%18:01 EDT
Volume:59.72K
Turnover:994.01K
Market Cap:107.61M
PE:-1.45
High:17.15
Open:16.41
Low:16.21
Close:16.00
Loading ...

BRIEF-Instil Bio Subsidiary Secures $85.6 Million Term Loan From Midland National Life Insurance Co

Reuters
·
24 Dec 2024

Instil Bio Inc - Co's Subsidiary Secures $85.6 Mln Term Loan From Midland National Life Insurance Co

THOMSON REUTERS
·
24 Dec 2024

Instil Bio Secures Loan to Refinance Facility

TIPRANKS
·
24 Dec 2024

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
21 Dec 2024

Thakral to enter India’s real estate sector; invests $6.37 mil in mixed-use development

Ashley Lo
·
16 Dec 2024

Prediction: This Stock Will Beat the Market in 2025

Motley Fool
·
12 Dec 2024

Here's Why Summit Therapeutics Stock Price Rose 6% on Friday

Zacks
·
09 Dec 2024

Is Iovance Biotherapeutics Stock a Millionaire Maker?

Motley Fool
·
27 Nov 2024

Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer

GlobeNewswire
·
27 Nov 2024

Iovance Biotherapeutics, Inc. (IOVA): Among the Most Promising Cancer Stocks According to Hedge Funds

Insider Monkey
·
23 Nov 2024

Iovance Biotherapeutics Inc. (IOVA): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts

Insider Monkey
·
22 Nov 2024

Strategic Acquisitions and Market Potential Position Instil Bio’s SYN-2510 as a Buy with High Growth Prospects

TIPRANKS
·
18 Nov 2024

Instil Bio Price Target Maintained With a $110.00/Share by HC Wainwright & Co.

Dow Jones
·
18 Nov 2024

Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer Therapy

Zacks
·
16 Nov 2024

BNTX to Boost Oncology Pipeline With Biotheus Acquisition, Stock Up

Zacks
·
14 Nov 2024

Instil Bio Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
14 Nov 2024

Instil Bio price target lowered to $110 from $120 at H.C. Wainwright

TIPRANKS
·
14 Nov 2024

Instil Bio (TIL) Gets a Hold from JMP Securities

TIPRANKS
·
14 Nov 2024

Instil Bio files $200M mixed securities shelf

TIPRANKS
·
14 Nov 2024

Instil Bio Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
13 Nov 2024